CellSeed Inc. (TYO:7776)

Market Cap	11.31B -14.4%
Revenue (ttm)	161.00M -19.1%
Net Income	-914.00M
EPS	-53.15
Shares Out	36.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	377,000
Average Volume	981,060
Open	299.00
Previous Close	300.00
Day's Range	295.00 - 312.00
52-Week Range	231.00 - 742.00
Beta	1.14
RSI	45.97
Earnings Date	May 12, 2026

About CellSeed

CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan. It is involved in the commercializing regenerative medicine using cell sheets. The company also offers cell cultureware services, and contract development and manufacturing services; UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides ThermoPlate III, a heating element; cellZscope, an automated cell monitoring systems; and cell sheet suppor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 44
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7776

Financial Performance

In 2021, CellSeed's revenue was 161.00 million, a decrease of -19.10% compared to the previous year's 199.00 million. Losses were -914.00 million, 16.7% more than in 2020.